Related Experiment Video
Updated: Dec 26, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.0K
Functional neuroimaging in subjective cognitive decline: current status and a research path forward
Raymond P Viviano1,2, Jessica S Damoiseaux3,4
1Department of Psychology, Wayne State University, 5057 Woodward Ave. 7th Floor Suite 7908, Detroit, MI, 48201, USA.
Alzheimer'S Research & Therapy
|March 11, 2020
Summary
Subjective cognitive decline may signal early dementia. Functional neuroimaging can detect brain changes and track progression, even when the cause is unclear, offering a potential intervention point.
Area of Science:
- Neuroscience
- Cognitive Aging
- Medical Imaging
Background:
- Subjective cognitive decline (SCD) is a perceived worsening of cognition without objective deficits.
- SCD may precede dementia, but requires objective biomarkers for intervention.
- Current biomarkers are often disease-specific, limiting application in unclear etiologies.
Purpose of the Study:
- To review functional neuroimaging studies in subjective cognitive decline.
- To reconcile inconsistent findings in the literature.
- To propose a functional model for SCD and guide future research.
Main Methods:
- Review of functional neuroimaging studies investigating subjective cognitive decline.
- Analysis of data to identify patterns and inconsistencies.
- Development of a theoretical functional model based on network dynamics.
Main Results:
- Functional neuroimaging may detect subtle brain changes associated with SCD.
- Inconsistent findings suggest variability in underlying pathophysiology or measurement sensitivity.
- A proposed model highlights noisy signal propagation and inefficient processing in brain networks.
Conclusions:
- Functional neuroimaging offers a disorder-agnostic approach to track cognitive decline.
- The proposed model suggests network dysfunction underlies the subjective experience of cognitive decline.
- Future research should focus on refining neuroimaging techniques and validating the functional model.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Cognitive Development During Adulthood
691
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
691
Dementia
456
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
456
Brain Imaging
589
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
589

